Drug Information

Drug General Information
Drug ID
D04MGW
Former ID
DNCL003448
Drug Name
BI-836858
Drug Type
Antibody
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Phase 1 [524065]
Company
Boehringer Ingelheim Pharmaceuticals
Target and Pathway
Target(s) Myeloid cell surface antigen CD33 Target Info [532771]
KEGG Pathway Hematopoietic cell lineage
Reactome Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
References
Ref 524065ClinicalTrials.gov (NCT01690624) BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia. U.S. National Institutes of Health.
Ref 532771The past and future of CD33 as therapeutic target in acute myeloid leukemia. Blood Rev. 2014 Jul;28(4):143-53.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.